683 Capital Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

683 Capital Management’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,027	Closed	-$56K	–	338
2022 Q3	$56K	Hold	4,027	–	–	﹤0.01%	165
2022 Q2	$162K	Hold	4,027	–	–	0.01%	179
2022 Q1	$424K	Hold	4,027	–	–	0.02%	194
2021 Q4	$464K	Hold	4,027	–	–	0.02%	208
2021 Q3	$1.52M	Buy	4,027 +1,627	+68%	+$546K	0.06%	123
2021 Q2	$979K	Hold	2,400	–	–	0.03%	150
2021 Q1	$1.15M	Buy	+2,400	New	+$1.31M	0.06%	120

Other funds holding NEXI

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

683 Capital Management's NEXI Position: Q4 2022 in Review

683 Capital Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2022, closing a stake of 4,027 shares — an estimated $56K sold.

683 Capital Management first reported a position in NEXI in Q1 2021 and held it in 7 quarters. The position peaked at $1.52M in Q3 2021. 29 funds tracked by Wall St. Rank hold NEXI as of Q4 2022.

683 Capital Management reported no remaining NexImmune, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
683 Capital Management sold 4,027 NexImmune, Inc. Common Stock shares in Q4 2022, an estimated $56K.
683 Capital Management first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
683 Capital Management's NexImmune, Inc. Common Stock position peaked at $1.52M in Q3 2021.
29 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2022.

Based on 683 Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.